64 related articles for article (PubMed ID: 10419650)
1. Ingested interferon alpha induces Mx mRNA.
Brod SA; Nelson L; Jin R; Wolinsky JS
Cytokine; 1999 Jul; 11(7):492-9. PubMed ID: 10419650
[TBL] [Abstract][Full Text] [Related]
2. Oral administration of IFN-alpha is superior to subcutaneous administration of IFN-alpha in the suppression of chronic relapsing experimental autoimmune encephalomyelitis.
Brod SA; Khan M
J Autoimmun; 1996 Feb; 9(1):11-20. PubMed ID: 8845048
[TBL] [Abstract][Full Text] [Related]
3. IFN-gamma regulates murine interferon-inducible T cell alpha chemokine (I-TAC) expression in dendritic cell lines and during experimental autoimmune encephalomyelitis (EAE).
Hamilton NH; Banyer JL; Hapel AJ; Mahalingam S; Ramsay AJ; Ramshaw IA; Thomson SA
Scand J Immunol; 2002 Feb; 55(2):171-7. PubMed ID: 11896933
[TBL] [Abstract][Full Text] [Related]
4. MxA gene expression in peripheral blood mononuclear cells from patients infected chronically with hepatitis C virus treated with interferon-alpha.
Meier V; Mihm S; Ramadori G
J Med Virol; 2000 Nov; 62(3):318-26. PubMed ID: 11055241
[TBL] [Abstract][Full Text] [Related]
5. Ingested (oral) IFN-alpha represses TNF-alpha mRNA in relapsing-remitting multiple sclerosis.
Brod SA; Nguyen M; Hood Z; Shipley GL
J Interferon Cytokine Res; 2006 Mar; 26(3):150-5. PubMed ID: 16542137
[TBL] [Abstract][Full Text] [Related]
6. Th1/Th2 type cytokines in hepatitis B patients treated with interferon-alpha.
Xing T; Zhang L; Lu Q; Hou J; Feng X; Luo K
Chin Med J (Engl); 2001 Sep; 114(9):921-4. PubMed ID: 11780382
[TBL] [Abstract][Full Text] [Related]
7. Immune effects observed after the injection of plasmids coding for rainbow trout (Oncorhynchus mykiss) CK5B, CK6 and CK7A chemokines demonstrate their immunomodulatory capacity and reveal CK6 as a major interferon inducer.
Montero J; Chaves-Pozo E; Cuesta A; Tafalla C
Dev Comp Immunol; 2009 Oct; 33(10):1137-45. PubMed ID: 19539644
[TBL] [Abstract][Full Text] [Related]
8. Methylthioadenosine reverses brain autoimmune disease.
Moreno B; Hevia H; Santamaria M; Sepulcre J; Muñoz J; García-Trevijano ER; Berasain C; Corrales FJ; Avila MA; Villoslada P
Ann Neurol; 2006 Sep; 60(3):323-34. PubMed ID: 16786535
[TBL] [Abstract][Full Text] [Related]
9. Activity of feline interferon-omega after ocular or oral administration in cats as indicated by Mx protein expression in conjunctival and white blood cells.
Bracklein T; Theise S; Metzler A; Spiess BM; Richter M
Am J Vet Res; 2006 Jun; 67(6):1025-32. PubMed ID: 16740097
[TBL] [Abstract][Full Text] [Related]
10. Ingested (oral) SIRS peptide 1-21 inhibits acute EAE by inducing Th2-like cytokines.
Brod SA; Hood Z
J Neuroimmunol; 2007 Feb; 183(1-2):89-95. PubMed ID: 17196668
[TBL] [Abstract][Full Text] [Related]
11. Induction of MxA mRNA in patients with neuroendocrine tumors after interferon treatment. Lack of correlation with antitumor response.
Imam H; Janson ET; Gobl A; Alm G; Oberg K
Anticancer Res; 1995; 15(5B):2191-5. PubMed ID: 8572623
[TBL] [Abstract][Full Text] [Related]
12. Infectious pancreatic necrosis virus suppresses type I interferon signalling in rainbow trout gonad cell line but not in Atlantic salmon macrophages.
Collet B; Munro ES; Gahlawat S; Acosta F; Garcia J; Roemelt C; Zou J; Secombes CJ; Ellis AE
Fish Shellfish Immunol; 2007; 22(1-2):44-56. PubMed ID: 16713304
[TBL] [Abstract][Full Text] [Related]
13. Rapid and simple detection of IFN-neutralizing antibodies in chronic hepatitis C non-responsive to IFN-alpha.
Jorns C; Holzinger D; Thimme R; Spangenberg HC; Weidmann M; Rasenack J; Blum HE; Haller O; Kochs G
J Med Virol; 2006 Jan; 78(1):74-82. PubMed ID: 16299717
[TBL] [Abstract][Full Text] [Related]
14. Interferon beta-1a induces tumor necrosis factor receptor 1 but decreases tumor necrosis factor receptor 2 leukocyte mRNA levels in relapsing-remitting multiple sclerosis.
Reuss R; Pohle S; Retzlaff K; Hemberger J; Oschmann P
Neuroimmunomodulation; 2009; 16(3):171-6. PubMed ID: 19246939
[TBL] [Abstract][Full Text] [Related]
15. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
Youssef S; Stüve O; Patarroyo JC; Ruiz PJ; Radosevich JL; Hur EM; Bravo M; Mitchell DJ; Sobel RA; Steinman L; Zamvil SS
Nature; 2002 Nov; 420(6911):78-84. PubMed ID: 12422218
[TBL] [Abstract][Full Text] [Related]
16. Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression.
Krakauer M; Sorensen P; Khademi M; Olsson T; Sellebjerg F
Mult Scler; 2008 Jun; 14(5):622-30. PubMed ID: 18424480
[TBL] [Abstract][Full Text] [Related]
17. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
Miura Y; Thoburn CJ; Bright EC; Hess AD
Biol Blood Marrow Transplant; 2004 Mar; 10(3):156-70. PubMed ID: 14993881
[TBL] [Abstract][Full Text] [Related]
18. Adoptive transfer from interferon-alpha-fed mice is associated with inhibition of active experimental autoimmune encephalomyelitis by decreasing recipient tumor necrosis factor-alpha secretion.
Brod SA; Khan M; Nelson LD; Decuir B; Malone M; Henninger E
J Immunother; 2000; 23(2):235-45. PubMed ID: 10746550
[TBL] [Abstract][Full Text] [Related]
19. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
[TBL] [Abstract][Full Text] [Related]
20. [Up-regulation of thymidine phosphorylase and anti-angiogenesis by interferon alpha in human hepatocellular carcinoma cell line and xenograft].
Xiao YS; Zhou J; Tang ZY; Fan J; Wu ZQ; Liu YK; Ye SL; Shen ZZ; Xue Q; Zhao Y
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3205-9. PubMed ID: 16405841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
